Lun - Ven 8:00 - 17:00
H.; Abu Lila, A. S.; Unissa, R.; Elsewedy, H. S.; Elghamry, H. A.; Soliman, M. S. Preparation, characterization and evaluation of anti-inflammatory and anti-nociceptive effects of brucine-loaded nanoemulgel. Colloids Surf., B 2021, 205, 111868 DOI: 10.1016/j.colsurfb.2021.111868Google ScholarThere is no corresponding record for this reference. 11Paudel, K.
8Nichols, D. J.; Muirhead, G. J.; Harness, J. A. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.
2002, 53 (Suppl 1), 5S– 12S, DOI: 10.1046/j.0306-5251.2001.00027.xGoogle ScholarThere is no corresponding record for this reference. 9Hosny, K. M.; Alhakamy, N. A.; Almodhwahi, M. A.; Kurakula, M.; Almehmady, A. S.; Milewski, M.; Swadley, C. L.; Brogden, N. K.; Ghosh, P.; Stinchcomb, A. L. Challenges and opportunities in dermal/transdermal delivery.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 25mg | 360 + 10 Pills | 213.68€ 203.50€ | |
| Viagra Generic | 25mg | 90 + 6 Pills | 105.03€ 100.03€ | |
| Viagra Generic | 150mg | 10 Pills | 36.73€ 34.98€ | |
| Kamagra | 100mg | 20 Pills | 86.09€ 81.99€ | |
| Viagra Generic | 150mg | 20 Pills | 55.02€ 52.40€ | |
| Viagra Generic | 25mg | 270 + 8 Pills | 184.26€ 175.49€ | |
| Viagra Generic | 200mg | 180 + 10 Pills | 277.56€ 264.34€ | |
| Viagra Generic | 150mg | 120 + 8 Pills | 177.58€ 169.12€ | |
| Viagra Generic | 150mg | 180 + 10 Pills | 236.46€ 225.20€ | |
| Viagra Generic | 200mg | 270 + 10 Pills | 379.76€ 361.68€ |
Ther Deliv 2010, 1, 109– 131, DOI: 10.4155/tde.10.16Google Scholar11Challenges and opportunities in dermal/transdermal deliveryPaudel, Kalpana S.; Milewski, Mikolaj; Swadley, Courtney L.; Brogden, Nicole K.; Ghosh, Priyanka; Stinchcomb, Audra L.Therapeutic Delivery (2010), 1 (1), 109-131CODEN: TDHEA7; ISSN:2041-5990. Transdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs.
A response surface methodology was implemented for fabricating and optimizing a bilosomal formulation of sildenafil (SDF-BS). The optimized SDF-BS formulation was characterized in terms of its entrapment efficiency (EE), zeta potential, vesicle size, and in vitro release profile. The optimized formula was then loaded onto hydroxypropyl methyl cellulose (HPMC) hydrogel and assessed for skin permeation, in vivo pharmacokinetics, and pharmacodynamic studies. The optimized SDF-BS showed the following characteristic features; EE of 88.7 ± 1.1%, vesicle size of 185.0 + 9.2 nm, zeta potential of −20.4 ± 1.1 mV, and efficiently sustained SDF release for 12 h. Skin permeation study revealed a remarkable improvement in SDF penetration from bilosomal gel compared to plain SDF gel.
In addition, pharmacokinetic results revealed that encapsulating SDF within bilosomal vesicles significantly enhanced its systemic bioavailability (∼3 folds), compared to SDF oral suspension. In addition, pharmacodynamic investigation revealed that, compared to plain SDF gel or oral drug suspension, SDF-BS gel applied topically triggered a significant elevation (p < 0.05) in cGMP serum levels, underscoring the superior therapeutic efficacy of SDF-BS gel. Conclusively, bilosomes can be viewed as a promising nanocarrier for transdermal delivery of SDF that would grant higher therapeutic efficiency while alleviating the limitations encountered with SDF oral administration. You are free to share(copy and redistribute) this article in any medium or format within the parameters below: Creative Commons (CC): This is a Creative Commons license. Creative Commons (CC): This is a Creative Commons license.
Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited. This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug mols. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compds., macromols. and conventional drugs for new therapeutic indications.
J. Ther 2019, 26, e520– e526, DOI: 10.1097/MJT.0000000000000766Google ScholarThere is no corresponding record for this reference. 4Morcos, S. K. Can selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphadiesterase type 5 (PDE 5) offer protection against contrast induced nephropathy?.
2014, 4, 214– 215, DOI: 10.3978/j.issn.2223-4292.2014.06.01Google ScholarThere is no corresponding record for this reference. 2015, 61, 181– 192, DOI: 10.4103/0022-3859.159421Google ScholarThere is no corresponding record for this reference. 6Beghetti, M.; Rudzinski, A.; Zhang, M. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension. BMC Cardiovasc Disord 2017, 17, 177, DOI: 10.1186/s12872-017-0569-3Google ScholarThere is no corresponding record for this reference.
7Desai, K.; Di Lorenzo, M.; Zuckerman, W. A.; Emeruwa, E.; Krishnan, U. S. Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure. Children 2023, 10, 270, DOI: 10.3390/children10020270Google ScholarThere is no corresponding record for this reference. trials of a wide variety of drugs for various clin. conditions, there is a great future for transdermal delivery of drugs.
| Condition | Details | Reason |
|---|---|---|
| Temperature | 2°C to 25°C | Prevent degradation |
| Humidity | Below 60% | Avoid microbial growth |
| Light Exposure | Store in opaque container | Protect from photodegradation |
| Shelf Life | 24 months | Ensure efficacy over shelf life |
12Tanner, T.; Marks, R. Delivering drugs by the transdermal route: review and comment. Skin Research and Technology 2008, 14, 249– 260, DOI: 10.1111/j.1600-0846.2008.00316.xGoogle ScholarThere is no corresponding record for this reference. 13Andrews, S. N.; Jeong, E.; Prausnitz, M. R.
Carefully review the actual license before using these materials. License Summary* You are free to share(copy and redistribute) this article in any medium or format within the parameters below: Creative Commons (CC): This is a Creative Commons license. *Disclaimer This summary highlights only some of the key features and terms of the actual license. Each value is the mean ± SD of the three experiments. Q12: cumulative amount of SDF permeated per unit area in 12 h, Jss: steady state flux, and Jmax: maximum average drug flux after 12 h per unit area per hour.
Data presented as mean ± SD (n = 5). The Supporting Information is available free of charge at Impact of formulation variables (A) SPC amount; (B) Span 60 amount; and (C) SDC amount on the in vitro SDF release from various bilosomal lovegra sildenafil formulations; regression analysis of Y1 according to different polynomial models; results of statistical analysis for Y1 response according to the quadratic model; regression analysis of Y2 according to different polynomial models; results of statistical analysis for Y2 response according to the quadratic model; and stability study results of SDF-BS stored at 4 °C for 90 days (PDF) Impact of formulation variables (A) SPC amount; (B) Span 60 amount; and (C) SDC amount on the in vitro SDF release from various bilosomal formulations; regression analysis of Y1 according to different polynomial models; results of statistical analysis for Y1 response according to the quadratic model; regression analysis of Y2 according to different polynomial models; results of statistical analysis for Y2 response according to the quadratic model; and stability study results of SDF-BS stored at 4 °C for 90 days (PDF) Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: This study is supported via funding from Prince Sattam Bin Abdulaziz University project number (PSAU/2024/R/1445). The authors also extend their appreciation to the Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, for supporting this work under the researcher supporting project number (PNURSP2024R205).
Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system. Journal of Drug Delivery Science and Technology 2020, 55, 101444 DOI: 10.1016/j.jddst.2019.101444Google ScholarThere is no corresponding record for this reference. 2Hatzimouratidis, K. Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence. Aging 2006, 1, 403– 414, DOI: 10.2147/ciia.2006.1.4.403Google ScholarThere is no corresponding record for this reference. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. 2013, 30, 1099– 1109, DOI: 10.1007/s11095-012-0946-7Google ScholarThere is no corresponding record for this reference. 14Dhote, V.; Bhatnagar, P.; Mishra, P. K.; Mahajan, S. C.; Mishra, D.
K. Iontophoresis: a potential emergence of a transdermal drug delivery system.
2012, 80, 1– 28, DOI: 10.3797/scipharm.1108-20Google ScholarThere is no corresponding record for this reference. 15Denet, A. R.; Vanbever, R.; Préat, V. Skin electroporation for transdermal and topical delivery. 2004, 56, 659– 674, DOI: 10.1016/j.addr.2003.10.027Google Scholar15Skin electroporation for transdermal and topical deliveryDenet, Anne-Rose; Vanbever, Rita; Preat, VeroniqueAdvanced Drug Delivery Reviews (2004), 56 (5), 659-674CODEN: ADDREP; ISSN:0169-409X. Electroporation is the transitory structural perturbation of lipid bilayer membranes due to the application of high voltage pulses. Its application to the skin has been shown to increase transdermal drug delivery by several orders of magnitude. Moreover, electroporation, used alone or in combination with other enhancement methods, expands the range of drugs (small to macromols., lipophilic or hydrophilic, charged or neutral mols.) which can be delivered transdermally.
M.; Elgebaly, S. S. Self-Nanoemulsifying System Loaded with Sildenafil Citrate and Incorporated within Oral Lyophilized Flash Tablets: Preparation, Optimization, and In Vivo Evaluation. Pharmaceutics 2020, 12, 1124, DOI: 10.3390/pharmaceutics12111124Google ScholarThere is no corresponding record for this reference. 10Abdallah, M. transport through transiently permeabilized skin by electroporation results mainly from enhanced diffusion and electrophoresis.
Années d'expérience
Domaines d'interventions
Dans le cadre de notre stratégie, nous menons des actions locales dans les différentes écorégions cruciales, en visant des objectifs globaux.
Nous voulons nous assurer que les espèces les plus emblématiques et les plus menacées soient préservées et puissent évoluer librement dans la nature. Nous plaidons également pour le renforcement de l'intégrité de nos forêts les plus importantes et des avantages qu'elles procurent en termes de bien-être. Nous nous battons également pour que les futurs systèmes alimentaires soient durables et conformes aux critères de santé alimentaire. Enfin, il est nécessaire d'opérer une transition mondiale vers un avenir à faible émission de carbone.
Parce que chaque espèce joue un rôle particulier dans l’écosystème, elle est précieuse
En savoir plus
L'éducation environnementale sensibilise, surtout les jeunes, à nos ressources et à leur usage durable.
En savoir plus
L'écotourisme préserve la nature, implique les communautés locales et offre des expériences durables.
En savoir plus
Moins dépendance forestière, plus de sécurité alimentaire, préservation des ressources.
En savoir plusNos Projets
ODDB-ONG mène des actions écologiques pour soutenir les populations locales dans leurs efforts pour améliorer leur bien-être et celui de leur environnement.
Nous voulons nous assurer que les espèces les plus emblématiques et les plus menacées soient préservées et puissent évoluer librement dans la nature. Nous plaidons également pour le renforcement de l'intégrité de nos forêts les plus importantes et des avantages qu'elles procurent en termes de bien-être. Nous nous battons également pour que les futurs systèmes alimentaires soient durables et conformes aux critères de santé alimentaire. Enfin, il est nécessaire d'opérer une transition mondiale vers un avenir à faible émission de carbone.
Question à nous poser
Nos Statistiques
Années d'expérience
de superficies reboisées
personnes sensibilisées
personnes autonomisées
Stagiaires et bénévoles formés pour suivi de la biodiversité
Nos Actualités